Multitarget-Directed Drug Design Strategy: A Novel Molecule Designed To Block Epidermal Growth Factor Receptor (EGFR) and To Exert Proapoptotic Effects
- 21 October 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (23) , 6642-6645
Abstract
The multifactorial mechanistic nature of cancer calls for the development of multifunctional therapeutic tools, i.e., single compounds able to interact with multiple altered pathogenetic pathways. Following this rationale, we designed compounds able to irreversibly block epidermal growth factor receptor (EGFR), and to induce apoptosis in tumor cell lines. The novel molecules were synthesized by combining the structural features of the EGFR inhibitor PD153035 (1) and lipoic acid, which among other therapeutic effects triggers apoptosis in human cancer cells.Keywords
This publication has 18 references indexed in Scilit:
- The Combi-Targeting Concept: Synthesis of Stable Nitrosoureas Designed to Inhibit the Epidermal Growth Factor Receptor (EGFR)Journal of Medicinal Chemistry, 2006
- Free radicals, metals and antioxidants in oxidative stress-induced cancerChemico-Biological Interactions, 2006
- Role of Tyrosine Kinase Inhibitors in Cancer TherapyThe Journal of Pharmacology and Experimental Therapeutics, 2005
- α-lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2−.-generationApoptosis, 2005
- Multicomponent therapeutics for networked systemsNature Reviews Drug Discovery, 2005
- Comparison of Elisa-Based Tyrosine Kinase Assays for Screening EGFR InhibitorsJournal of Receptors and Signal Transduction, 2005
- Rational Approach To Discover Multipotent Anti-Alzheimer DrugsJournal of Medicinal Chemistry, 2004
- Signaling through the epidermal growth factor receptor during the development of malignancyPharmacology & Therapeutics, 2004
- EGF receptorThe International Journal of Biochemistry & Cell Biology, 1999
- Tyrosine Kinase Inhibitors. 6. Structure−Activity Relationships among N- and 3-Substituted 2,2‘-Diselenobis(1H-indoles) for Inhibition of Protein Tyrosine Kinases and Comparative in Vitro and in Vivo Studies against Selected Sulfur CongenersJournal of Medicinal Chemistry, 1997